An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
D000368:Aged; D001519:Behavior / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003072:Cognition Disorders / Q000188:drug therapy; D004644:Emotions / Q000187:drug effects; D004877:Ergoloid Mesylates / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D008297:Male; D010208:Papaverine / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D013997:Time Factors
D004877:Ergoloid Mesylates; D010208:Papaverine